United Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services
Go back to United Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 494.63 -2.64 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $497.27 | 52 Week High | $164.04 | |||
| Open | $498.07 | 52 Week Low | $97.52 | |||
| Day High | $499.23 | P/E | 90.43 | |||
| Day Low | $492.57 | EPS | $5.47 | |||
| Volume | 1,501,106 | |||||
